CCI approves Sun Pharma-Ranbaxy deal; creates India's largest pharma co
However, the approval did not come without its share of conditions as the CCI asked the two companies to divest some products as not to affect fair competition in the market.
Dec 08, 2014, 17:49 PM IST
Indian pharma cos should tap Latin American markets: Barclays
Indian pharmaceutical companies need to focus on the Latin American markets namely Brazil and Mexico, British brokerage firm Barclays has said.
Oct 09, 2014, 21:31 PM IST
DrReddy's, Sun Pharma among 14 firms probed by US over drug price
India's pharma majors Dr Reddy's and Sun Pharma are among 14 drug makers which are being probed by the US Congress over price escalation of generic drugs.
Oct 08, 2014, 21:06 PM IST
Govt strips pharma pricing regulator's powers to cap non-essential drug prices
The government has stripped drug pricing authority NPPA of powers to cap prices of non- essential drugs after its recent order triggered industry protests.
Sep 23, 2014, 11:22 AM IST
CCI says Sun-Ranbaxy deal may hit competition; seeks comments
In the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI on Thursday invited comments from all stakeholders, including general public, on finer details of USD 4-billion merger of Ranbaxy Labs into rival Sun Pharmaceuticals.
Sep 04, 2014, 12:13 PM IST
Pharma sector to continue growth in double digits: Moody's
The Indian pharmaceutical market will continue to grow in the double digits, representing a better growth opportunity than many other geographic markets, Moody's Investors Service says.
Aug 25, 2014, 16:06 PM IST
Govt extends deadline for pharma barcodes
The government has extended the deadline to affix barcodes on mono-carton (ointments, eye/ear drops) by pharmaceutical companies to April 2015.
Aug 18, 2014, 18:18 PM IST
Cipla gains after April-June margins expand sequentially
Shares in drugmaker Cipla gain after April-June operating margins beat some estimates.
Aug 18, 2014, 12:33 PM IST
Top 20 pharma companies' capex to surge by 40%: CRISIL
India's top 20 pharmaceutical companies would increase capital expenditure by 40 percent to more than Rs 50,000 crore by fiscal 2018, credit rating agency CRISIL said Wednesday.
Aug 13, 2014, 20:11 PM IST
Glenmark Pharma Q1 Net up 43.7% at Rs 184.8 crore
Glenmark Pharmaceuticals Thursday reported 43.7 percent jump in consolidated net profit at Rs 184.8 crore for the first quarter ended June 30, 2014.
Jul 24, 2014, 18:28 PM IST
